Skip to main content

Compare Stocks

Date Range: 

 AtriCureMerit Medical SystemsAxonicsNuVasiveCantel Medical
SymbolNASDAQ:ATRCNASDAQ:MMSINASDAQ:AXNXNASDAQ:NUVANYSE:CMD
Price Information
Current Price$72.60$59.38$54.41$70.38$83.05
52 Week RangeBuyBuyBuyHoldHold
MarketRank™
Overall Score1.71.71.51.21.3
Analysis Score3.52.42.51.21.0
Community Score2.92.72.82.72.4
Dividend Score0.00.00.00.00.0
Ownership Score1.71.71.70.01.7
Earnings & Valuation Score0.61.90.61.91.3
Analyst Ratings
Consensus RecommendationBuyBuyBuyHoldHold
Consensus Price Target$84.00$67.00$65.75$68.43$71.50
% Upside from Price Target15.70% upside12.83% upside20.84% upside-2.77% downside-13.91% downside
Trade Information
Market Cap$3.31 billion$3.33 billion$2.28 billion$3.64 billion$3.70 billion
Beta1.131.210.021.361.54
Average Volume398,787278,855568,874707,815510,889
Sales & Book Value
Annual Revenue$230.81 million$994.85 million$13.82 million$1.17 billion$1.02 billion
Price / Sales14.353.34164.983.113.64
CashflowN/A$3.57 per shareN/A$6.90 per share$3.66 per share
Price / CashN/A16.64N/A10.2022.69
Book Value$6.25 per share$17.21 per share$6.40 per share$17.58 per share$17.31 per share
Price / Book11.623.458.504.004.80
Profitability
Net Income$-35,190,000.00$5.45 million$-79,930,000.00$65.23 million$13.71 million
EPS($1.07)$1.46($2.80)$2.47$1.65
Trailing P/E RatioN/AN/AN/AN/A98.87
Forward P/E RatioN/A31.92N/A30.0828.54
P/E GrowthN/A2.40N/A1.791.57
Net Margins-21.74%-3.05%-76.62%-0.84%3.38%
Return on Equity (ROE)-14.83%9.02%-28.05%8.00%11.19%
Return on Assets (ROA)-7.77%4.91%-23.44%3.06%4.10%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/A-25.00%
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity Ratio0.15%0.37%0.02%0.85%1.28%
Current Ratio6.62%2.34%8.62%1.85%3.13%
Quick Ratio5.85%1.21%7.48%1.48%2.31%
Ownership Information
Institutional Ownership Percentage94.70%99.47%84.23%N/A95.01%
Insider Ownership Percentage5.80%4.70%25.74%0.89%10.70%
Miscellaneous
Employees7505,9894162,7003,669
Shares Outstanding45.63 million56.00 million41.90 million51.65 million44.51 million
Next Earnings Date7/27/2021 (Estimated)8/4/2021 (Estimated)8/5/2021 (Estimated)8/3/2021 (Estimated)6/3/2021 (Estimated)
OptionableOptionableOptionableNot OptionableOptionableOptionable
SourceHeadline
Mar Cor Launches Its Newest and Most Advanced Portable Reverse Osmosis Water SystemMar Cor Launches Its Newest and Most Advanced Portable Reverse Osmosis Water System
finance.yahoo.com - May 6 at 11:54 AM
CMD: What does Argus have to say about CMD?CMD: What does Argus have to say about CMD?
finance.yahoo.com - April 29 at 6:34 PM
Announcing: Cantel Medical (NYSE:CMD) Stock Increased An Energizing 168% In The Last YearAnnouncing: Cantel Medical (NYSE:CMD) Stock Increased An Energizing 168% In The Last Year
finance.yahoo.com - April 28 at 2:48 PM
Cantel (CMD) Hits 52-Week High, Can the Run Continue?Cantel (CMD) Hits 52-Week High, Can the Run Continue?
finance.yahoo.com - April 26 at 11:51 AM
Nuvectra (OTCMKTS:NVTRQ) & Cantel Medical (NYSE:CMD) Financial SurveyNuvectra (OTCMKTS:NVTRQ) & Cantel Medical (NYSE:CMD) Financial Survey
americanbankingnews.com - April 26 at 8:24 AM
Cantel Medical (NYSE:CMD) Reaches New 1-Year High at $89.35Cantel Medical (NYSE:CMD) Reaches New 1-Year High at $89.35
americanbankingnews.com - April 23 at 4:08 PM
SHAREHOLDER ALERT: WeissLaw LLP Reminds CMD, ATH, WIFI, and FLIR Shareholders About Its Ongoing InvestigationsSHAREHOLDER ALERT: WeissLaw LLP Reminds CMD, ATH, WIFI, and FLIR Shareholders About Its Ongoing Investigations
finance.yahoo.com - April 16 at 5:30 PM
Amedisys (AMED) Inks Deal to Extend Home Health Care OperationsAmedisys (AMED) Inks Deal to Extend Home Health Care Operations
finance.yahoo.com - April 15 at 10:06 AM
STERIS Irish FinCo Unlimited Company -- Moodys announces completion of a periodic review of ratings of STERIS plcSTERIS Irish FinCo Unlimited Company -- Moody's announces completion of a periodic review of ratings of STERIS plc
finance.yahoo.com - April 12 at 5:49 PM
INVESTIGATION ALERT: Halper Sadeh LLP Investigates COHR, FFG, CMD, MDCA, BPFH; Shareholders are Encouraged to Contact the FirmINVESTIGATION ALERT: Halper Sadeh LLP Investigates COHR, FFG, CMD, MDCA, BPFH; Shareholders are Encouraged to Contact the Firm
finance.yahoo.com - April 12 at 2:40 PM
SHAREHOLDER ALERT: WeissLaw LLP Reminds TPCO, EGOV, GWPH, and CMD Shareholders About Its Ongoing InvestigationsSHAREHOLDER ALERT: WeissLaw LLP Reminds TPCO, EGOV, GWPH, and CMD Shareholders About Its Ongoing Investigations
finance.yahoo.com - April 7 at 5:22 PM
BD (BDX) Receives FDA EUA for Combination Rapid Antigen TestBD (BDX) Receives FDA EUA for Combination Rapid Antigen Test
finance.yahoo.com - March 31 at 1:13 PM
Varian Medical (VAR) Hits 52-Week High: Whats Driving It?Varian Medical (VAR) Hits 52-Week High: What's Driving It?
finance.yahoo.com - March 26 at 12:22 PM
INVESTIGATION ALERT: Halper Sadeh LLP Investigates PMBC, CMD, COHR, PRSP, FLIR, BPFH; Shareholders are Encouraged to Contact the FirmINVESTIGATION ALERT: Halper Sadeh LLP Investigates PMBC, CMD, COHR, PRSP, FLIR, BPFH; Shareholders are Encouraged to Contact the Firm
finance.yahoo.com - March 25 at 6:17 AM
STERIS Irish FinCo Unlimited Company -- Moodys assigns Baa2 rating to STERIS Irish FinCo senior notesSTERIS Irish FinCo Unlimited Company -- Moody's assigns Baa2 rating to STERIS Irish FinCo senior notes
finance.yahoo.com - March 24 at 1:57 PM
SHAREHOLDER ALERT: WeissLaw LLP Reminds EGOV, GWPH, PRSP and CMD Shareholders About Its Ongoing InvestigationsSHAREHOLDER ALERT: WeissLaw LLP Reminds EGOV, GWPH, PRSP and CMD Shareholders About Its Ongoing Investigations
finance.yahoo.com - March 17 at 5:22 PM
STERIS plc -- Moodys assigns Baa2 issuer rating to STERIS plcSTERIS plc -- Moody's assigns Baa2 issuer rating to STERIS plc
finance.yahoo.com - March 17 at 12:21 PM
Cantel Medical (CMD) Shines in Alger Small Cap’s 2020 PortfolioCantel Medical (CMD) Shines in Alger Small Cap’s 2020 Portfolio
finance.yahoo.com - March 15 at 1:03 PM
Looking for a Growth Stock? 3 Reasons Why Cantel (CMD) is a Solid ChoiceLooking for a Growth Stock? 3 Reasons Why Cantel (CMD) is a Solid Choice
finance.yahoo.com - March 12 at 3:57 PM
What Makes Cantel (CMD) a New Buy StockWhat Makes Cantel (CMD) a New Buy Stock
finance.yahoo.com - March 11 at 1:57 PM
CMD or ABMD: Which Is the Better Value Stock Right Now?CMD or ABMD: Which Is the Better Value Stock Right Now?
finance.yahoo.com - March 11 at 12:31 PM
Cantel Medical Shares Spike 4% On 2Q BeatCantel Medical Shares Spike 4% On 2Q Beat
smarteranalyst.com - March 10 at 6:29 AM
Cantel Medical (CMD) Q2 Earnings and Revenues Top EstimatesCantel Medical (CMD) Q2 Earnings and Revenues Top Estimates
finance.yahoo.com - March 9 at 12:38 PM
Cantel Medical Corp. 2021 Q2 - Results - Earnings Call PresentationCantel Medical Corp. 2021 Q2 - Results - Earnings Call Presentation
seekingalpha.com - March 9 at 9:34 AM
Cantel: Fiscal Q2 Earnings SnapshotCantel: Fiscal Q2 Earnings Snapshot
whig.com - March 9 at 7:38 AM
DateCompanyBrokerageAction
5/17/2021AtriCureNeedham & Company LLCReiterated Rating
5/14/2021AtriCureJPMorgan Chase & Co.Boost Price Target
5/4/2021AtriCureOppenheimerBoost Price Target
5/4/2021AtriCureCanaccord GenuityBoost Price Target
4/29/2021AtriCurePiper SandlerBoost Price Target
4/29/2021AtriCureSVB LeerinkReiterated Rating
4/28/2021AtriCureBTIG ResearchBoost Price Target
5/6/2021Merit Medical SystemsRaymond JamesBoost Price Target
4/30/2021Merit Medical SystemsBarrington ResearchBoost Price Target
11/11/2020Merit Medical SystemsWells Fargo & CompanyBoost Price Target
10/29/2020Merit Medical SystemsSidotiBoost Price Target
5/13/2021AxonicsMorgan StanleyBoost Price Target
1/26/2021AxonicsRobert W. BairdBoost Price Target
11/5/2020AxonicsTruistBoost Price Target
10/23/2020AxonicsGuggenheimInitiated Coverage
3/31/2021NuVasiveCitigroup Inc. 3% Minimum Coupon Principal Protected Based Upon RussellBoost Price Target
12/16/2020NuVasiveSmith Barney CitigroupUpgrade
10/23/2020Cantel MedicalCJS SecuritiesInitiated Coverage
8/19/2020Cantel MedicalBank of AmericaInitiated Coverage
(Data available from 5/18/2018 forward. View 10+ years of historical ratings with our analyst ratings screener.)
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.